ATLASDrug Manufacturers - General earnings calendar: upcoming and recent reports
7 Drug Manufacturers - General companies report earnings over the next 45 days, led by Amgen (AMGN), Novo Nordisk A/S (NVO) and Pfizer (PFE). 9 reported over the last 45 days; 100% of those with an EPS estimate came in above it.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS Signals lists the biggest reports of the week, with ATLAS’s read on each, plus three stocks on our radar. One email, one-click unsubscribe.
ATLAS Signals
ATLAS Signals, every week
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy
Drug Manufacturers - General: upcoming earnings (next 45 days)
| Company | Date | Time | EPS est. | ATLAS chance up (1 mo) | Likely range (50%) | Fair value vs price |
|---|---|---|---|---|---|---|
| Amgen AMGN · ATLAS page | Tue, Nov 3 | After close | $5.74 | 51% | $444.95 – $490.51 | $459.42 ($272.07–$594.37) · 1% above |
| Pfizer PFE · ATLAS page | Tue, Nov 3 | Before open | $0.72 | 53% | $29.51 – $31.81 | $36.78 ($28.69–$67.48) · 17% below |
| Novo Nordisk A/S NVO · ATLAS page | Wed, Nov 4 | Before open | $0.81 | 51% | $37.97 – $42.29 | $32.69 ($24.29–$46.13) · 22% above |
| Organon & Co. OGN · ATLAS page | Mon, Nov 9 | – | $0.95 | 53% | $13.40 – $14.41 | – |
| Mira Pharmaceuticals MIRA · ATLAS page | Thu, Nov 12 | – | – | 45% | $0.46 – $0.62 | – |
| Scilex Holding Co. SCLX · ATLAS page | Fri, Nov 13 | – | – | 45% | $1.52 – $2.11 | – |
| Medicus Pharma MDCX · ATLAS page | Fri, Nov 13 | – | -$8.50 | 40% | $1.27 – $2.24 | – |
ATLAS columns: chance of a higher price in 1 month, the likely 1-month price range and the fair value with its range, from each company’s ATLAS page. They describe an ordinary period, not the earnings reaction.
Drug Manufacturers - General: recent earnings results (last 45 days)
| Company | Date | Time | EPS est. | EPS reported | Surprise | Move* | ATLAS chance up (1 mo) | Likely range (50%) | Fair value vs price |
|---|---|---|---|---|---|---|---|---|---|
| AbbVie ABBV · ATLAS page | Fri, Oct 30 | – | $3.74 | $3.82 | +2.1% | – | 53% | $285.46 – $307.06 | $156.39 ($122.65–$199.42) · 89% above |
| AstraZeneca AZN · ATLAS page | Fri, Oct 30 | – | $2.60 | $2.79 | +7.3% | – | 50% | $176.03 – $198.25 | $232.68 ($168.27–$339.55) · 20% below |
| Eli Lilly LLY · ATLAS page | Thu, Oct 29 | – | $5.38 | $7.48 | +39.0% | – | 50% | $1,330.79 – $1,510.54 | $677.93 ($511.11–$899.20) · 109% above |
| Merck & Co. MRK · ATLAS page | Thu, Oct 29 | – | $2.12 | $2.49 | +17.5% | – | 51% | $142.02 – $158.00 | $88.37 ($62.03–$125.88) · 69% above |
| Gilead Sciences GILD · ATLAS page | Thu, Oct 29 | – | $2.17 | $2.55 | +17.5% | – | 51% | $162.62 – $179.94 | $177.75 ($140.51–$224.86) · 4% below |
| Bristol-Myers Squibb BMY · ATLAS page | Thu, Oct 29 | – | $1.21 | $1.35 | +11.6% | – | 51% | $59.49 – $65.91 | $119.46 ($96.48–$147.92) · 48% below |
| Biogen BIIB · ATLAS page | Wed, Oct 28 | – | $2.06 | $2.62 | +27.2% | – | 51% | $240.41 – $268.40 | $183.87 ($120.78–$279.91) · 38% above |
| Novartis AG NVS · ATLAS page | Tue, Oct 27 | – | $2.25 | $2.46 | +9.3% | +1.5% | 51% | $153.12 – $169.58 | $257.05 ($197.59–$390.76) · 37% below |
| Johnson & Johnson JNJ · ATLAS page | Tue, Oct 13 | – | $2.53 | $2.59 | +2.4% | -3.8% | 52% | $262.55 – $286.13 | $183.73 ($126.84–$255.15) · 49% above |
ATLAS columns: chance of a higher price in 1 month, the likely 1-month price range and the fair value with its range, from each company’s ATLAS page. They describe an ordinary period, not the earnings reaction.
*Move: change in the closing price from the last close before the report day to the close the day after it.
Largest Drug Manufacturers - General companies and their next report
- Eli Lilly (LLY)
- Johnson & Johnson (JNJ)
- AbbVie (ABBV)
- Merck & Co. (MRK)
- Novartis AG (NVS)
- AstraZeneca (AZN)
- Amgen (AMGN) · Nov 3
- Gilead Sciences (GILD)
- Novo Nordisk A/S (NVO) · Nov 4
- Pfizer (PFE) · Nov 3
- Bristol-Myers Squibb (BMY)
- Biogen (BIIB)
- Organon & Co. (OGN) · Nov 9
- Nasus Pharma (NSRX)
- Mira Pharmaceuticals (MIRA) · Nov 12
- Scilex Holding Co. (SCLX) · Nov 13
- Medicus Pharma (MDCX) · Nov 13
Earnings calendar: frequently asked questions
Which Drug Manufacturers - General companies report earnings soon?
Amgen (AMGN), Novo Nordisk A/S (NVO), Pfizer (PFE), Organon & Co. (OGN), Mira Pharmaceuticals (MIRA) and Scilex Holding Co. (SCLX) are among the largest Drug Manufacturers - General reports scheduled in the next 45 days. 7 are listed with a confirmed date.
How many Drug Manufacturers - General companies beat EPS estimates?
Of the 9 Drug Manufacturers - General companies that reported over the last 45 days with an EPS estimate on record, 9 (100%) reported EPS above the estimate. That is a snapshot of one window, not a forecast.
Where do these Drug Manufacturers - General dates come from?
Dates are confirmed report dates from company and exchange data, refreshed daily. Estimated dates are never shown here; only individual company pages show an ATLAS estimate, clearly labelled.
What is the difference between before the open and after the close?
Reports released before the open (BMO) move the stock in that same session. Reports released after the close (AMC) are first reflected the next trading day. ATLAS shows the time when the exchange data provides it.
Other industries
- Full US earnings calendar
- Biotechnology earnings
- Banks - Regional earnings
- Software - Application earnings
- Software - Infrastructure earnings
- Medical Devices earnings
- Asset Management earnings
- Aerospace & Defense earnings
- Capital Markets earnings
- Drug Manufacturers - Specialty & Generic earnings
- Specialty Industrial Machinery earnings
- Information Technology Services earnings
- Oil & Gas E&P earnings
Open any company page to set an email alert for its next report. Looking for a single stock? Try Apple (AAPL).
Educational information, not investment advice. Disclaimer